Sandra Patterson
Insightful analysis on the companies, events, and strategic shifts truly moving the world's markets.
About This Column
Sandra Patterson is a commentator and strategist who explores the intersection of corporate performance and market sentiment. Building on her background in analyzing high-stakes volatility, Sandra now delivers daily dispatches on the broad forces reshaping the 2026 investment landscape - from the impact of "AI fatigue" to the re-emergence of value stocks. With a reputation for providing a nuanced perspective on "the why behind the buy," she offers a unique lens on the catalysts that drive market momentum. Her writing is essential reading for anyone seeking to stay ahead of the curve in a complex and rapidly changing world.
Displaying items 381-400 of 824 in total
Loomis Sets Green Precedent with Landmark Climate Targets
dynaCERT's Hydrogen Tech Targets Vietnam's Decarbonization Goals
Nevada Explorer Unlocks Antimony and Gold From Old Mining Waste
ViewSonic Sets New Green Benchmark with EPEAT 2.0 Monitor
Maxed AI Raises $850K to Automate Accounting with AI Agents
Metro Strike Widens, Threatening Quebec's Fresh Produce Supply
Helen of Troy's Costly Reset: Can a New Strategy Overcome Record Losses?
Strategic Education's EdTech Lifeline Tows Legacy University Units
Materialise Q1 Earnings: Can Medical Growth Lift a Divided Company?
Soaring Ambitions: CAA Fuels India's Pilot Pipeline After 18 Years
HCRx Bets Big on Brain Cancer Drug Modeyso in New Royalty Deal
New Hope for Pancreatic Cancer's Pain: Autonomix's Nerve-Targeting Tech
From Solo Shop to Industry Leader: Margy Sweeney’s Vision Rewrites PR Rules
JU's Robot Studio Puts Students at the Forefront of AI and Automation
PLEZi's Power Play: Obama & Currys Take On Sports Drink Giants
Operant AI Launches Guard Against High-Speed AI Agent Attacks
FyterTech Boosts US Supply Chain with Seattle & Nashville Hubs
Travelers' $24M Giving: More Than Charity, It's Strategic Investment
ProRx Pharma’s Expansion Shadowed by FDA Safety Violations
